22:04 , Oct 4, 2018 |  BC Extra  |  Company News

Management tracks: Grail, Nimbus

Cancer detection company Grail Inc. (Menlo Park, Calif.) hired Renée Galá as its first CFO, effective Jan. 3. Gala is SVP and CFO at Theravance Biopharma Inc. (NASDAQ:TBPH). Grail launched in 2016 and has raised...
23:05 , Aug 1, 2018 |  BC Innovations  |  Translation in Brief

New Therapeutic Targets and Biomarkers: July 2018

New Therapeutic Targets and Biomarkers: July 2018...
22:52 , Jul 20, 2018 |  BioCentury  |  Finance

JOBS Jolt 3.0?

The latest iteration of the JOBS Act could make it easier for biotechs to go public -- and raise more money more quickly -- but that doesn’t necessarily mean the quality of the IPO queue...
17:12 , Jul 20, 2018 |  BC Week In Review  |  Financial News

Allakos spikes after pricing upsized IPO above range

Allakos Inc. (NASDAQ:ALLK) gained $13.25 (74%) to $31.25 July 19 after it raised $128.4 million through the sale of 7.1 million shares at $18 in an upsized IPO. Goldman Sachs, Jefferies and William Blair are...
14:27 , Jul 19, 2018 |  BC Extra  |  Financial News

Allakos spikes after pricing upsized IPO above range

Allakos Inc. (NASDAQ:ALLK) gained $13.25 (74%) to $31.25 Thursday after it raised $128.4 million through the sale of 7.1 million shares at $18 in an upsized IPO. Goldman Sachs, Jefferies and William Blair are underwriters....
21:39 , Jun 23, 2018 |  BC Extra  |  Financial News

Latest batch of IPO filings: Rubius, Constellation, Replimune, Allakos

As a busy week for IPO pricings came to a close, several more companies filed for NASDAQ listings late Friday, further stocking an IPO pipeline of companies likely to seek liquidity during a tight calendar...
19:31 , Jun 15, 2018 |  BC Week In Review  |  Financial News

Alta closes $130M fund for biotechs, tech-based healthcare services

Alta Partners (San Francisco, Calif.) closed its Alta Partners NextGen Fund I at $130 million to invest in biotech and healthcare delivery companies. Alta told BioCentury the fund will invest in about six to eight...
21:13 , Jun 12, 2018 |  BC Extra  |  Financial News

Alta closes $130M fund for biotechs, tech-based healthcare services

Alta Partners closed its Alta Partners NextGen Fund I at $130 million to invest in biotech and healthcare delivery companies. Alta told BioCentury the fund will invest in about six to eight companies. Alta has...
14:48 , Apr 6, 2018 |  BC Week In Review  |  Clinical News

Allakos reports Phase I data for AK002 in healthy volunteers

Allakos Inc. (San Carlos, Calif.) reported data from a Phase I trial in healthy volunteers showing that single doses of 0.001-1 mg/kg IV AK002 were generally well tolerated. The company is developing the non-fucosylated IgG1...
16:27 , Dec 15, 2017 |  BC Week In Review  |  Financial News

Allakos raises $100M in series B

Allakos Inc. (San Carlos, Calif.) raised $100 million in a series B round led by New Enterprise Associates. Redmile Group, Partner Fund Management, Rock Springs Capital, LifeSci Venture Partners, Samsara BioCapital and an undisclosed institutional...